Ruthenium,[N-[(1R,2R)-2-(amino-kN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]- CAS:192139-92-7

Ruthenium, [N-[(1R,2R)-2-(amino-kN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene], has shown promising applications in catalysis, particularly in the field of organic synthesis. Its unique ligand structure and coordination environment impart specific catalytic properties, enabling its use in a variety of chemical transformations. This complex has been studied as a catalyst for the selective functionalization of organic molecules, including the modification of aromatic compounds, the formation of carbon-carbon and carbon-heteroatom bonds, and the synthesis of chiral compounds. In addition to catalysis, Ruthenium, [N-[(1R,2R)-2-(amino-kN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene], has been investigated for its potential applications in materials science. Its coordination chemistry and reactivity make it a candidate for the design and synthesis of novel materials with potential applications in catalysis, sensing, and electronic devices. Research efforts have focused on utilizing this complex as a precursor for the development of ruthenium-containing materials, including thin films, nanoparticles, and coordination polymers, for various technological applications. Furthermore, this ruthenium complex has drawn interest in medicinal chemistry research. Its structural features and potential reactivity with biomolecules have prompted investigations into its biological activity and potential applications in medicinal chemistry, such as in the development of novel pharmaceutical agents or as a tool for studying biological processes. Studies in this area aim to explore the biological properties and potential therapeutic applications of this complex. In summary, Ruthenium, [N-[(1R,2R)-2-(amino-kN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene], exhibits potential applications in catalysis, materials science, and medicinal chemistry. Its unique coordination environment and reactivity make it a subject of interest for the development of new catalytic systems, functional materials, and potential therapeutic agents.